O. B. , M. S. , S. Q. , E. Lainey, L. H. et al.,

M. S. , T. L. , R. P. , J. D. , F. S. et al.,

O. B. , M. S. , G. S. , and J. , wrote the manuscript; and all authors approved the manuscript and the submission

, Conflict-of-interest disclosure: The authors declare no competing financial interests, pp.0-0002

C. Av and . Vellefaux,

, e-mail: jean.soulier@sls.aphp.fr; and Gérard Socié, Hematology/Transplantation APHP, p.1

C. Av and . Vellefaux, , p.75010

A. Shimamura and B. P. Alter, Pathophysiology and management of inherited bone marrow failure syndromes, Blood Rev, vol.24, issue.3, pp.101-122, 2010.

I. Dokal and T. Vulliamy, Inherited bone marrow failure syndromes, Haematologica, 2010.

D. M. Townsley, B. Dumitriu, and N. S. Young, Bone marrow failure and the telomeropathies, Blood, vol.124, issue.18, pp.2775-2783, 2014.

D. B. Wilson, D. C. Link, P. J. Mason, and M. Bessler, Inherited bone marrow failure syndromes in adolescents and young adults, Ann Med, vol.46, issue.6, pp.353-363, 2014.

C. M. Niemeyer and I. Baumann, Classification of childhood aplastic anemia and myelodysplastic syndrome, Hematology Am Soc Hematol Educ Program, pp.84-89, 2011.

D. P. Steensma, Cytopenias 1 mutationsdysplasia 5 what?, Blood, vol.126, issue.21, pp.2349-2351, 2015.

L. Malcovati and M. Cazzola, The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)

, Hematology Am Soc Hematol Educ Program, vol.2015, pp.299-307, 2015.

N. S. Young, The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated, Blood, vol.79, issue.6, pp.1385-1392, 1992.

S. Ogawa, Clonal hematopoiesis in acquired aplastic anemia, Blood, vol.128, issue.3, pp.337-347, 2016.

R. Peffault-de-latour, C. Peters, and B. Gibson,

, Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Recommendations on GENETIC LANDSCAPE OF IBMF blood® 15 FEBRUARY 2018 | VOLUME, vol.131, p.731

E. Gluckman and J. E. Wagner, Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome, Bone Marrow Transplant, vol.41, issue.2, pp.127-132, 2008.

R. Peffault-de-latour and J. Soulier, How I treat MDS and AML in Fanconi anemia, Blood, vol.127, issue.24, pp.2971-2979, 2016.

S. A. Savage and A. A. Bertuch, The genetics and clinical manifestations of telomere biology disorders, Genet Med, vol.12, issue.12, pp.753-764, 2010.

A. Shimamura, Aplastic anemia and clonal evolution: germ line and somatic genetics, Hematology Am Soc Hematol Educ Program, vol.2016, issue.1, pp.74-82, 2016.

M. Y. Zhang, S. B. Keel, and T. Walsh, Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity, Haematologica, vol.100, issue.1, pp.42-48, 2015.

I. Ghemlas, H. Li, and B. Zlateska, Improving diagnostic precision, care and syndrome definitions using comprehensive nextgeneration sequencing for the inherited bone marrow failure syndromes, J Med Genet, vol.52, issue.9, pp.575-584, 2015.

H. Muramatsu, Y. Okuno, and K. Yoshida, Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes

, Genet Med, vol.19, issue.7, pp.796-802, 2017.

F. O. Pinto, T. Leblanc, and D. Chamousset, Diagnosis of Fanconi anemia in patients with bone marrow failure, Haematologica, 2009.

J. Soulier, T. Leblanc, and J. Larghero, Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway, Blood, vol.105, issue.3, pp.1329-1336, 2005.

Q. Waisfisz, N. V. Morgan, and M. Savino, Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism, Nat Genet, vol.22, issue.4, pp.379-383, 1999.

T. Le-guen, F. Touzot, and I. Andre-schmutz, An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation, J Allergy Clin Immunol, vol.136, issue.6, pp.1619-1626, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01252419

M. C. Jongmans, E. T. Verwiel, and Y. Heijdra, Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita, Am J Hum Genet, vol.90, issue.3, pp.426-433, 2012.

E. Papaemmanuil, M. Gerstung, and L. Malcovati, Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, issue.22, p.3699, 2013.

S. Jaiswal, P. Fontanillas, and J. Flannick, Agerelated clonal hematopoiesis associated with adverse outcomes, N Engl J Med, vol.371, issue.26, pp.2488-2498, 2014.

M. Xie, C. Lu, and J. Wang, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat Med, vol.20, issue.12, pp.1472-1478, 2014.

J. E. Churpek, K. Pyrtel, and K. L. Kanchi, Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia, Blood, vol.126, issue.22, pp.2484-2490, 2015.

D. A. Arber, A. Orazi, and R. Hasserjian, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-2405, 2016.

S. Richards, N. Aziz, and S. Bale, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 2015.

J. Nadaf, J. Majewski, and S. Fahiminiya, ExomeAI: detection of recurrent allelic imbalance in tumors using whole-exome sequencing data, Bioinformatics, vol.31, issue.3, pp.429-431, 2015.

C. W. Rehder, K. L. David, B. Hirsch, H. V. Toriello, C. M. Wilson et al., American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing, Genet Med, vol.15, issue.2, pp.150-152, 2013.

J. E. Posey, T. Harel, and P. Liu, Resolution of disease phenotypes resulting from multilocus genomic variation, N Engl J Med, vol.376, issue.1, pp.21-31, 2017.

M. Tarailo-graovac, C. Shyr, and C. J. Ross, Exome sequencing and the management of neurometabolic disorders, N Engl J Med, vol.374, issue.23, pp.2246-2255, 2016.

A. Nagamachi, H. Matsui, and H. Asou, Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7, Cancer Cell, vol.24, issue.3, pp.305-317, 2013.

I. Chefetz, B. Amitai, D. Browning, and S. , Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein, J Invest Dermatol, vol.128, issue.6, pp.1423-1429, 2008.

J. Liu and G. Mcfadden, SAMD9 is an innate antiviral host factor with stress response properties that can be antagonized by poxviruses, J Virol, vol.89, issue.3, pp.1925-1931, 2015.

T. Niihori, M. Ouchi-uchiyama, and Y. Sasahara, Mutations in MECOM, encoding oncoprotein EVI1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia, Am J Hum Genet, vol.97, issue.6, pp.848-854, 2015.

H. Tummala, M. Kirwan, and A. J. Walne, ERCC6L2 mutations link a distinct bonemarrow-failure syndrome to DNA repair and mitochondrial function, Am J Hum Genet, vol.94, issue.2, pp.246-256, 2014.

S. Zhang, C. Pondarre, and G. Pennarun, A nonsense mutation in the DNA repair factor Hebo causes mild bone marrow failure and microcephaly, J Exp Med, vol.213, issue.6, pp.1011-1028, 2016.

D. H. Chen, J. E. Below, and A. Shimamura, Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L, Am J Hum Genet, vol.98, issue.6, pp.1146-1158, 2016.

B. Tesi, J. Davidsson, and M. Voss, Gain-offunction SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms, Blood, vol.129, issue.16, pp.2266-2279, 2017.

S. Narumi, N. Amano, and T. Ishii, SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7, Nat Genet, vol.48, issue.7, pp.792-797, 2016.

F. Buonocore, P. Kühnen, and J. P. Suntharalingham, Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans, J Clin Invest, vol.127, issue.5, pp.1700-1713, 2017.

L. A. Godley and A. Shimamura, Genetic predisposition to hematologic malignancies: management and surveillance, Blood, vol.130, issue.4, pp.424-432, 2017.